Daniel Bischoff Email & Phone Number

Ingelheim Am Rhein, Rhineland-Palatinate, De

The Drug Discovery Sciences (DDS) Department in Vienna and Biberach is the data warehouse of BI`s global Discovery Research organization encompassing General Pharmacology, CMC, DMPK, Bioanalysis and Biomarker, High Throughput Biology and Target Discovery Sciences.DDS is a critical driver for BI`s Research productivity and innovation in Oncology, Immunology & Respiratory, CNS and Cardiometabolic Diseases as well as Research Beyond Borders for our Research Sites in USA, Austria and Germany.The core mission of the Department is to leverage cutting-edge science and technology to best assess and predict all key parameters relevant to translate preclinical into clinical data.

Ingelheim Am Rhein, Rhineland-Palatinate, De

The Drug Discovery Sciences Department is the data warehouse of BI`s global Discovery Research organization encompassing General Pharmacology, CMC, DMPK, Bioanalysis and Biomarker, High Throughput Biology and Target Discovery Sciences and is therefore a critical driver for BI`s Research productivity and innovation.The core mission of the Department is to leverage cutting-edge science and technology to best assess and predict all key parameters relevant to translate preclinical into clinical data.

Ingelheim Am Rhein, Rhineland-Palatinate, De

High Throughput Biology is a core function in the BI Research network and global skill center for all HTS activities. In addition, HT Biology is responsible for medium throughput in vitro pharmacology assays for all Discovery Research activities at our German and US Research Sites from Exploratory Research to Start of Development. The core competence of HT Biology is the translation of disease biology into physiological relevant screening and profiling assays and to employ cutting-edge readout and automation technology.

Ingelheim Am Rhein, Rhineland-Palatinate, De

The Core Mission of the Drug Metabolism and Bioanalysis unit is the mass spec based characterization of pharmacokinetics and drug metabolism of NCEs, to optimize DMPK properties of drug candidates and assess their developability.

Ingelheim Am Rhein, Rhineland-Palatinate, De

Ingelheim Am Rhein, Rhineland-Palatinate, De

Dr. Rer. Nat. (Ph.D.), Thesis: “The Biosynthesis Of Vancomycin-Type Antibiotics”

Diplom-Chemiker, Chemistry

Erasmus Fellowship, Synthesis Of Cisplatin Analogous Gold(Iii) Compounds